Baxter Recalls Parenteral Nutrition Injection Products

Baxter is recalling two lots of Clinimix and one lot of Clinimix E premixed sterile parenteral nutrition products over complaints of particulate matter.

The affected lots were distributed to healthcare centers and distributors in the U.S. between May 2012 and Oct. 2013. Customers should remove affected lots from their facilities and return them to Baxter for credit, the drugmaker says.

The FDA has been notified, though no adverse events have been reported. Baxter also claims that the root cause of the particulates has been identified and corrected.

Requests to Baxter for more details about its root cause investigation were not returned by press time Monday. — Lena Freund

Subscribe to Drug Industry Daily for complete coverage of the pharmaceutical industry. Click here for more information.